These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 29211853)

  • 1. Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice.
    Zhao S; Ghosh A; Lo CS; Chenier I; Scholey JW; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Endocrinology; 2018 Feb; 159(2):836-852. PubMed ID: 29211853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual RAS blockade normalizes angiotensin-converting enzyme-2 expression and prevents hypertension and tubular apoptosis in Akita angiotensinogen-transgenic mice.
    Lo CS; Liu F; Shi Y; Maachi H; Chenier I; Godin N; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2012 Apr; 302(7):F840-52. PubMed ID: 22205225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice.
    Abdo S; Shi Y; Otoukesh A; Ghosh A; Lo CS; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Diabetes; 2014 Oct; 63(10):3483-96. PubMed ID: 24812425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of heterogeneous nuclear ribonucleoprotein F stimulates renal Ace-2 gene expression and prevents TGF-β1-induced kidney injury in a mouse model of diabetes.
    Lo CS; Shi Y; Chang SY; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Diabetologia; 2015 Oct; 58(10):2443-54. PubMed ID: 26232095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of catalase prevents hypertension and tubulointerstitial fibrosis and normalization of renal angiotensin-converting enzyme-2 expression in Akita mice.
    Shi Y; Lo CS; Chenier I; Maachi H; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Am J Physiol Renal Physiol; 2013 Jun; 304(11):F1335-46. PubMed ID: 23552863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Nrf2 in Renal Proximal Tubular Cells Stimulates Sodium-Glucose Cotransporter 2 Expression and Exacerbates Dysglycemia and Kidney Injury in Diabetic Mice.
    Zhao S; Lo CS; Miyata KN; Ghosh A; Zhao XP; Chenier I; Cailhier JF; Ethier J; Lattouf JB; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Diabetes; 2021 Jun; 70(6):1388-1403. PubMed ID: 33820760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous nuclear ribonucleoprotein F suppresses angiotensinogen gene expression and attenuates hypertension and kidney injury in diabetic mice.
    Lo CS; Chang SY; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Diabetes; 2012 Oct; 61(10):2597-608. PubMed ID: 22664958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
    Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
    Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The angiotensin converting enzyme 2/angiotensin-(1-7)/Mas Receptor axis as a key player in alveolar bone remodeling.
    Queiroz-Junior CM; Santos ACPM; Galvão I; Souto GR; Mesquita RA; Sá MA; Ferreira AJ
    Bone; 2019 Nov; 128():115041. PubMed ID: 31442676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel roles of the renal angiotensin-converting enzyme.
    Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
    Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin Inhibits Nrf2 Gene Expression via Heterogeneous Nuclear Ribonucleoprotein F/K in Diabetic Mice.
    Ghosh A; Abdo S; Zhao S; Wu CH; Shi Y; Lo CS; Chenier I; Alquier T; Filep JG; Ingelfinger JR; Zhang SL; Chan JSD
    Endocrinology; 2017 Apr; 158(4):903-919. PubMed ID: 28324005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury.
    Ali Q; Dhande I; Samuel P; Hussain T
    J Renin Angiotensin Aldosterone Syst; 2016 Jul; 17(3):. PubMed ID: 27496559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type 2 receptor and angiotensin-converting enzyme 2 mediate ischemic renal injury in diabetic and non-diabetic rats.
    Sharma N; Malek V; Mulay SR; Gaikwad AB
    Life Sci; 2019 Oct; 235():116796. PubMed ID: 31470003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Nephropathy Induced by Increased Ace Gene Dosage Is Associated with High Renal Levels of Angiotensin (1-7) and Bradykinin.
    Bertoncello N; Moreira RP; Arita DY; Aragão DS; Watanabe IK; Dantas PS; Santos R; Mattar-Rosa R; Yokota R; Cunha TS; Casarini DE
    J Diabetes Res; 2015; 2015():674047. PubMed ID: 26442284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex dimorphism in ANGII-mediated crosstalk between ACE2 and ACE in diabetic nephropathy.
    Clotet-Freixas S; Soler MJ; Palau V; Anguiano L; Gimeno J; Konvalinka A; Pascual J; Riera M
    Lab Invest; 2018 Sep; 98(9):1237-1249. PubMed ID: 29884907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).
    Bernardi S; Burns WC; Toffoli B; Pickering R; Sakoda M; Tsorotes D; Grixti E; Velkoska E; Burrell LM; Johnston C; Thomas MC; Fabris B; Tikellis C
    Clin Sci (Lond); 2012 Jul; 123(1):29-37. PubMed ID: 22288735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme 2 mediates hyperfiltration associated with diabetes.
    Tikellis C; Brown R; Head GA; Cooper ME; Thomas MC
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F773-80. PubMed ID: 24477684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.
    Callera GE; Antunes TT; Correa JW; Moorman D; Gutsol A; He Y; Cat AN; Briones AM; Montezano AC; Burns KD; Touyz RM
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27612496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.